Compare, Analyse Torrent Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,964383-   
Low Rs1,245276-   
Sales per share (Unadj.) Rs453.4113.9-  
Earnings per share (Unadj.) Rs25.8-28.7-  
Cash flow per share (Unadj.) Rs62.3-23.8-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs279.289.4-  
Shares outstanding (eoy) m169.22168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.52.9 122.3%   
Avg P/E ratio x62.2-11.5 -541.9%  
P/CF ratio (eoy) x25.8-13.9 -185.9%  
Price / Book Value ratio x5.73.7 155.9%  
Dividend payout %65.90-   
Avg Mkt Cap Rs m271,51355,608 488.3%   
No. of employees `00013.64.3 316.7%   
Total wages/salary Rs m14,0383,490 402.2%   
Avg. sales/employee Rs Th5,642.64,476.9 126.0%   
Avg. wages/employee Rs Th1,032.4813.0 127.0%   
Avg. net profit/employee Rs Th320.9-1,128.1 -28.4%   
INCOME DATA
Net Sales Rs m76,72819,219 399.2%  
Other income Rs m571135 423.9%   
Total revenues Rs m77,29919,354 399.4%   
Gross profit Rs m19,831-3,331 -595.4%  
Depreciation Rs m6,177829 744.7%   
Interest Rs m5,038521 967.6%   
Profit before tax Rs m9,187-4,546 -202.1%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5700-   
Tax Rs m1,254284 441.3%   
Profit after tax Rs m4,363-4,843 -90.1%  
Gross profit margin %25.8-17.3 -149.1%  
Effective tax rate %13.6-6.2 -218.4%   
Net profit margin %5.7-25.2 -22.6%  
BALANCE SHEET DATA
Current assets Rs m50,37514,076 357.9%   
Current liabilities Rs m51,6537,920 652.2%   
Net working cap to sales %-1.732.0 -5.2%  
Current ratio x1.01.8 54.9%  
Inventory Days Days92111 83.0%  
Debtors Days Days68124 55.1%  
Net fixed assets Rs m83,6488,205 1,019.5%   
Share capital Rs m84689 948.3%   
"Free" reserves Rs m46,3970-   
Net worth Rs m47,24415,085 313.2%   
Long term debt Rs m39,1295,301 738.1%   
Total assets Rs m141,20928,497 495.5%  
Interest coverage x2.8-7.7 -36.5%   
Debt to equity ratio x0.80.4 235.7%  
Sales to assets ratio x0.50.7 80.6%   
Return on assets %6.7-15.2 -43.9%  
Return on equity %9.2-32.1 -28.8%  
Return on capital %12.3-19.8 -62.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m16,5810-   
CASH FLOW
From Operations Rs m17,9811,640 1,096.1%  
From Investments Rs m-2,413-504 479.0%  
From Financial Activity Rs m-13,1454,811 -273.2%  
Net Cashflow Rs m2,3805,948 40.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.28 Rs / ZAR

Compare TORRENT PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: ALKEM LABORATORIES  SUVEN LIFE SCIENCES  PANACEA BIOTECH  WOCKHARDT  CADILA HEALTHCARE  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

TORRENT PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - TTK HEALTHCARE COMPARISON

COMPARE TORRENT PHARMA WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS